Skip to main content
Kothari Fermanatation & Biochem Ltd logo

Kothari Fermanatation & Biochem Ltd — Investor Relations & Filings

Ticker · 507474 ISIN · INE991B01010 BSE.NS Manufacturing
Filings indexed 318 across all filing types
Latest filing 2025-12-22 Regulatory Filings
Country IN India
Listing BSE.NS 507474

About Kothari Fermanatation & Biochem Ltd

https://www.kothariyeast.in

Kothari Fermentation & Biochem Ltd specializes in the production of yeast and yeast-based derivatives through advanced fermentation technology. The company's primary product portfolio includes compressed yeast, dried yeast, and instant dry yeast, marketed under the brand name Sunrise. These products cater extensively to the bakery and food processing industries. Additionally, the firm operates in the biochemical sector, producing industrial alcohol, extra neutral alcohol, and rectified spirits. Utilizing integrated manufacturing processes, the company focuses on high-quality biochemical solutions for diverse industrial applications, including the beverage and pharmaceutical sectors. Its operations emphasize technical precision in fermentation to ensure product consistency and performance in commercial baking and industrial fermentation processes.

Recent filings

Filing Released Lang Actions
Please refer to the attached annexure.
Regulatory Filings Classification · 95% confidence The document is an official communication addressed to the stock exchange (BSE Limited) reporting the outcome of a Board Meeting held on December 22, 2025. It includes the approval of the re-appointment of internal auditors and notes on loan facilities. The document references compliance with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The content is an announcement of decisions made at the Board Meeting rather than a full report or detailed financial statements. The document length is 3759 characters, which is relatively short and consistent with a regulatory announcement rather than a full report. There is no detailed financial data or comprehensive report content. Therefore, this document fits best as a Regulatory Filing (RNS) under SEBI regulations, reporting material events and board decisions.
2025-12-22 English
Newspaper publication regarding the Special Window for Re-lodgment of transfer request of physical shares and RTA report.
Regulatory Filings
2025-11-22 English
Intimation under Regulation 30 & 47 w.r.t Newspaper publication of Unaudited Financial Results for the quarter and half-year ended September 30, 2025
Regulatory Filings
2025-11-15 English
Annexure attached as per the subject.
Regulatory Filings
2025-11-14 English
Outcome of the Board Meeting held on Friday, November 14, 2025, w.r.t the Approval of Unaudited Financial Results for the quarter and half-year ended on September 30, 2025.
Regulatory Filings
2025-11-14 English
Kothari Fermentation & Biochem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve the Unaudited ....
Regulatory Filings
2025-11-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.